Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

Autor: Rosenstock J, Samols E, Muchmore DB, Schneider J, Glimepirade Study Group, Rosenstock, J, Samols, E, Muchmore, D B, Schneider, J
Zdroj: Diabetes Care; Nov1996, Vol. 19 Issue 11, p1194-1199, 6p
Databáze: Complementary Index